Status:
COMPLETED
Effect of Insoles in Patients With Systemic Lupus Erythematosus
Lead Sponsor:
University of Seville
Conditions:
Lupus Erythematosus, Systemic
Foot Orthoses
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Demonstrate that custom-made insoles improve painful symptomatology, health and foot function in subjects with SLE and podiatric involvement.
Eligibility Criteria
Inclusion
- 18 years or more.
- Medical diagnosis of LES.
- Foot involvement.
Exclusion
- Treatment with foot orthoses.
- LES with acute symptomatic flare.
- Ulcers.
- Skin involvement.
- Neurological problems.
- Cognitive deterioration.
- Need for walking assistance.
- Refused to change footwear to use the foot orthoses.
Key Trial Info
Start Date :
November 2 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 2 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04098055
Start Date
November 2 2019
End Date
February 2 2022
Last Update
May 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Podiatry
Seville, Spain, 41009